Granted Patent
B2
US 7,763,449 · App. 12/273,566 · Granted Jul 27, 2010
Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence that is at least one residue long
Assignee:
Alfacell Corporation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A nucleic acid encodes a novel RNase. The RNase has an amino acid sequence in which an amino acid sequence disclosed in U.S. Pat. No. 6,239,257 B1 is preceded by a different N-terminal residue or leader sequence.
Claims (2)
1. An isolated gene that encodes a protein having the amino acid sequence of SEQ ID NO: 60.
2. A vector containing the DNA of SEQ ID NO: 18 encoding the ribonuclease of SEQ ID NO: 17.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 10, 2020
From: TAMIR BIOTECHNOLOGY, INC.
To: ORGENESIS INC.
Reel/Frame 052892/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 27, 2020
From: SAXENA, SHAILENDRA K.
To: ALFACELL CORPORATION
Reel/Frame 052241/0958 →
CHANGE OF NAME
Recorded Mar 27, 2020
From: ALFACELL CORPORATION
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052251/0288 →
Continuity (3)